Cargando…
Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL
Bromodomain and extraterminal protein (BET) inhibitors suppress the expression of c-MYC. U266, a human myeloma cell line, expresses the MYCL gene, but not the c-MYC gene. Our aim was to analyse the antimyeloma activity of BET inhibitors on U266 cells. Two BET inhibitors, I-BET151 and JQ1, were teste...
Autores principales: | Suzuki, Kazuhito, Yamamoto, Kouhei, Arakawa, Yasuhiro, Yamada, Hisashi, Aiba, Keisuke, Kitagawa, Masanobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969056/ https://www.ncbi.nlm.nih.gov/pubmed/27276402 http://dx.doi.org/10.1097/CAD.0000000000000389 |
Ejemplares similares
-
Baicalein Inhibits Proliferation of Myeloma U266 Cells by Downregulating IKZF1 and IKZF3
por: Liu, Xiao-Ping, et al.
Publicado: (2018) -
Bisphosphonates as antimyeloma drugs
por: Modi, N D, et al.
Publicado: (2012) -
MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells
por: Kato, Fuyumi, et al.
Publicado: (2016) -
Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model
por: Vo, Manh-Cuong, et al.
Publicado: (2018) -
In vitro comparison of the cytotoxic effects of statins on U266 myeloma cell line
por: Terzi, Hatice, et al.
Publicado: (2019)